University of British Columbia-Department of Psychology, 2136 West Mall, Vancouver V6T 1Z4, Canada.
J Sex Med. 2009 Nov;6(11):2922-39; quiz 2940-1. doi: 10.1111/j.1743-6109.2009.01370.x.
Sexual function following genital sexual reassignment surgery (SRS) is an important outcome for many transsexuals, affecting the choice of surgical technique, satisfaction with surgery, and quality of life. However, compared to other outcome measures, little clinical and research attention has been given to sexual functioning following SRS.
To discuss the potential impact of cross-sex hormone therapy and SRS on sexual function and to summarize the published empirical research on postsurgical sexual functioning in male-to-female (MtF) and female-to-male (FtM) transsexuals.
Cross-sex hormone therapy and SRS techniques are outlined, the potential roles of cross-sex hormone therapy and SRS on sexual function are discussed, and peer-reviewed literature published in English on postoperative sexual functioning in MtF and FtM transsexuals is reviewed.
Sexual desire, sexual arousal, and ability to achieve orgasm following SRS.
Contrary to early views, transsexualism does not appear to be associated with a hyposexual condition. In MtF transsexuals, rates of hypoactive sexual desire disorder (HSDD) are similar to those found in the general female population. In FtM transsexuals, sexual desire appears unequivocally to increase following SRS. Studies with MtF transsexuals have revealed not only vasocongestion, but also the secretion of fluid during sexual arousal. Research on sexual arousal in FtM transsexuals is sorely lacking, but at least one study indicates increased arousal following SRS. The most substantial literature on sexual functioning in postoperative transsexuals pertains to orgasm, with most reports indicating moderate to high rates of orgasmic functioning in both MtF and FtM transsexuals.
Based on the available literature, transsexuals appear to have adequate sexual functioning and/or high rates of sexual satisfaction following SRS. Further research is required to understand fully the effects of varying types and dosages of cross-sex hormone therapies and particular SRS techniques on sexual functioning.
性器官性别重置手术后（SRS）的性功能是许多跨性别者的重要结果，影响手术技术的选择、对手术的满意度和生活质量。然而，与其他结果衡量标准相比，很少有临床和研究关注 SRS 后性功能。
讨论跨性激素治疗和 SRS 对性功能的潜在影响，并总结已发表的关于男性到女性（MtF）和女性到男性（FtM）跨性别者手术后性功能的实证研究。
概述跨性激素治疗和 SRS 技术，讨论跨性激素治疗和 SRS 对性功能的潜在作用，并回顾以英语发表的关于 MtF 和 FtM 跨性别者手术后性功能的同行评审文献。
SRS 后性欲、性唤起和达到性高潮的能力。
与早期观点相反，跨性别似乎与低性欲状况无关。在 MtF 跨性别者中，低性欲障碍（HSDD）的发生率与普通女性人群相似。在 FtM 跨性别者中，性欲似乎在 SRS 后明显增加。对 MtF 跨性别者的研究不仅揭示了血管充血，还揭示了性唤起期间液体的分泌。FtM 跨性别者性唤起的研究严重缺乏，但至少有一项研究表明 SRS 后性唤起增加。关于手术后跨性别者性功能的最具影响力的文献涉及到性高潮，大多数报告表明 MtF 和 FtM 跨性别者的性高潮功能中等至高度。
根据现有文献，跨性别者在 SRS 后似乎具有足够的性功能和/或高性满意度。需要进一步研究以充分了解不同类型和剂量的跨性激素治疗和特定 SRS 技术对性功能的影响。
